Cancer Proteins Are a New Weapon Against Alzheimer’s
In a Nutshell
A new Cell paper reveals that cancers (lung, colon, prostate) reduce amyloid plaques and improve cognition in Alzheimer's mouse models via secreted proteins, especially **cystatin C**, which binds amyloid, activates brain immune cells for clearance, and reverses memory deficits—though human applications remain uncertain due to blood-brain barrier challenges. Nick, a high-risk neuroscientist, protects his brain with: **LPC-DHA** (superior brain uptake vs. regular fish oil), low-dose **lithium orotate** (5mg daily, inhibits GSK3β and breaks amyloid vicious cycle), and **NMN/NR** (1g daily to boost NAD levels and preserve cognition). This discovery highlights cancer-Alzheimer's inverse links but emphasizes evidence-based prevention over risky shortcuts.
These notes were generated by AI and may contain inaccuracies.
One of the world's top science journals published a biological plot twist: cancer might kill Alzheimer's disease. Nick is an MD/PhD neuroscientist at high risk for Alzheimer's disease, spending time finding ways to protect his brain long-term. This research discovery shows cancer and Alzheimer's colliding in a way that might reveal new treatment paths. The video reviews the data, graphs, what researchers did and found, boiling down to one protein. Then shares evidence-backed actions Nick does to protect his brain, none involving getting cancer.
Part one reviews new data on how cancer-secreted proteins, one in particular, fight Alzheimer's and what it might mean. Part two provides high-yield review of supplements for cognitive longevity and Alzheimer's prevention that Nick uses. More research and deep dives at staycuriousmetabolism.com.
Prior epidemiological studies hinted people with cancer or history of cancer have significantly lower incidence of Alzheimer's disease. Researchers started with animal models to show causal cascade, testing lung, colon, and prostate cancer in mice predisposed to Alzheimer's disease. Implanted cancers, then examined brains focusing on amyloid, a core pathological feature.
In all three cancer groups across multiple brain regions—cortex, thalamus, dentate gyrus (important in memory), basolateral amygdala (important in limbic system and emotion)—mice with cancer had markedly reduced amyloid plaque levels. Primary data shows red and green staining images and bar graphs quantifying levels: red is control Alzheimer's mouse, other colors are Alzheimer's mice with cancer showing much lower amyloid levels.
Sign in to read the full notes
Get access to AI-generated notes, topic timestamps, and more.